Report Detail
Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Insights, Forecast to 2025
- RnM3386277 |
- 06 May, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Other
Staphylococcus aureus is a bacteria commonly found on nose or skin of healthy people. MRSA i.e., methicillin-resistant staphylococcus aureus, is thus a type of staphylococcus aureus that is resistant to beta-lactam antibiotic called methicillin. MRSA strains do not respond to methicillin treatment. Around 1% of the population carrying staphylococcus aureus on their nose or skin are infected by MRSA.
The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs in these regions.
This research report categorizes the global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market by top players/brands, region, type and end user. This report also studies the global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Theravance Biopharma
Basilea Pharmaceutica
Pfizer
Debiopharm Group
Merck
Allergan
Melinta Therapeutics
AmpliPhi Biosciences Corporation
KYORIN Pharmaceutical.
Baxter International
Market size by Product
Synthetic Drugs
Semisynthetic
Market size by End User
Oral Administration
Parenteral
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Growth Rate by Product
- 1.4.2 Synthetic Drugs
- 1.4.3 Semisynthetic
- 1.5 Market by End User
- 1.5.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Growth Rate by End User
- 1.5.2 Oral Administration
- 1.5.3 Parenteral
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size
- 2.1.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue 2014-2025
- 2.1.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales 2014-2025
- 2.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Growth Rate by Regions
- 2.2.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Regions
- 2.2.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Manufacturers
- 3.1.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Manufacturers
- 3.1.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Manufacturers
- 3.2.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Price by Manufacturers
- 3.4 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Product
- 4.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Product
- 4.3 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Breakdown Data by End User
6 North America
- 6.1 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Countries
- 6.1.1 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Countries
- 6.1.2 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Product
- 6.3 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by End User
7 Europe
- 7.1 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Countries
- 7.1.1 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Countries
- 7.1.2 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Product
- 7.3 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Countries
- 8.1.1 Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Countries
- 8.1.2 Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Product
- 8.3 Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by End User
9 Central & South America
- 9.1 Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Countries
- 9.1.1 Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Countries
- 9.1.2 Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Product
- 9.3 Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Countries
- 10.1.1 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Countries
- 10.1.2 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Product
- 10.3 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by End User
11 Company Profiles
- 11.1 Theravance Biopharma
- 11.1.1 Theravance Biopharma Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
- 11.1.5 Theravance Biopharma Recent Development
- 11.2 Basilea Pharmaceutica
- 11.2.1 Basilea Pharmaceutica Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Basilea Pharmaceutica Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Basilea Pharmaceutica Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
- 11.2.5 Basilea Pharmaceutica Recent Development
- 11.3 Pfizer
- 11.3.1 Pfizer Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Pfizer Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Pfizer Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
- 11.3.5 Pfizer Recent Development
- 11.4 Debiopharm Group
- 11.4.1 Debiopharm Group Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Debiopharm Group Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Debiopharm Group Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
- 11.4.5 Debiopharm Group Recent Development
- 11.5 Merck
- 11.5.1 Merck Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Merck Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Merck Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
- 11.5.5 Merck Recent Development
- 11.6 Allergan
- 11.6.1 Allergan Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Allergan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Allergan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
- 11.6.5 Allergan Recent Development
- 11.7 Melinta Therapeutics
- 11.7.1 Melinta Therapeutics Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Melinta Therapeutics Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Melinta Therapeutics Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
- 11.7.5 Melinta Therapeutics Recent Development
- 11.8 AmpliPhi Biosciences Corporation
- 11.8.1 AmpliPhi Biosciences Corporation Company Details
- 11.8.2 Company Business Overview
- 11.8.3 AmpliPhi Biosciences Corporation Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 AmpliPhi Biosciences Corporation Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
- 11.8.5 AmpliPhi Biosciences Corporation Recent Development
- 11.9 KYORIN Pharmaceutical.
- 11.9.1 KYORIN Pharmaceutical. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 KYORIN Pharmaceutical. Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 KYORIN Pharmaceutical. Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
- 11.9.5 KYORIN Pharmaceutical. Recent Development
- 11.10 Baxter International
- 11.10.1 Baxter International Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Baxter International Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Baxter International Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
- 11.10.5 Baxter International Recent Development
12 Future Forecast
- 12.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Forecast by Regions
- 12.1.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Forecast by Product
- 12.2.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Product 2019-2025
- 12.3 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Forecast by End User
- 12.4 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Forecast
- 12.5 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Forecast
- 12.6 Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Forecast
- 12.7 Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Forecast
- 12.8 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs . Industry analysis & Market Report on Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs is a syndicated market report, published as Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
